Singapore, July 7 -- TheDepartment of Health - Abu Dhabi(DoH), the regulator of the healthcare sector in the Emirate,M42, a global health champion powered by artificial intelligence (AI), technology and genomics and PureHealth, the largest healthcare group in the Middle East, plan to partner withGEMMABioTherapeutics (GEMMABio), a pioneering global biotechnology company dedicated to advancing global access to gene therapies for rare diseases.

Through this strategic partnership, the entities will jointly establish dedicated manufacturing and research centres within Abu Dhabi's academic health institutions, enabling patients from across the MENA region to access cutting-edge clinical trials and, eventually, approved gene therapies.

The col...